Longeveron

valentines day fail
Biotech

Longeveron’s phase 2b stem cell flop spurs cost cutting

The failure of the pediatric heart disease trial prompted the cash-strapped biotech to “review all options” for the business.
Nick Paul Taylor Sep 17, 2026 4:40am
Yellow Paraglider Flying Over the Peaks of the French Alps

Roche taps Aussie oncologist to lead research—Chutes & Ladders

Feb 20, 2026 8:30am
Professional kite surfer soars through the air

Merck KGaA lands new R&D chief—Chutes & Ladders

Sep 5, 2025 8:30am
parasailing over clouds in Salzburg Austria

Incyte, FDA, Sun Pharma and more—Chutes & Ladders

Jun 27, 2025 8:30am
photo of a paraglider in the foreground with the alps in the background

Flagship-backed biotechs name new leaders—Chutes & Ladders

Nov 15, 2024 8:30am
airplane landing flight end land plane runway

With cash runways ending, Nicox and Longeveron plan layoffs

Feb 28, 2024 10:30am